Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Dare Bioscience, Inc. (DARE) had Profit Margin of -157505.10% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.00M |
|
$-3.56M |
|
-- |
|
$0.00M |
|
$3.67M |
|
$-3.67M |
|
$0.11M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.67M |
|
$-3.07M |
|
12.76M |
|
12.76M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$25.00M |
|
$1.66M |
|
$5.74M |
|
$30.75M |
|
$21.22M |
|
$0.17M |
|
$6.67M |
|
$27.89M |
|
$2.86M |
|
$2.86M |
|
$2.86M |
|
13.93M |
|
| Cash Flow Statement Financials | |
$-11.33M |
|
$-0.18M |
|
$18.85M |
|
$16.00M |
|
$23.38M |
|
$7.38M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.18 |
|
-- |
|
-- |
|
0.05 |
|
0.71 |
|
100.00% |
|
-162340.80% |
|
-162340.80% |
|
-- |
|
-157505.10% |
|
|
Profit Margin |
-157505.10% |
$-11.51M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.01M |
|
-124.66% |
|
-124.66% |
|
-11.59% |
|
-117.85% |
|
$0.21 |
|
$-0.90 |
|
$-0.89 |
|